Treatment of iron overload in the "ex-thalassemic" - Report from the Phlebotomy Program

被引:31
作者
Angelucci, E [1 ]
Muretto, P
Lucarelli, G
Ripalti, M
Baronciani, D
Erer, B
Galimberti, M
Annibali, M
Giardini, C
Gaziev, D
Rapa, S
Polchi, P
机构
[1] Azienda Osped Pesaro, Div Ematol Muraglia, I-61100 Pesaro, Italy
[2] Azienda Osped Pesaro, Ctr Trapianto Midollo Osseo, I-61100 Pesaro, Italy
[3] Azienda Osped Pesaro, Serv Anat Patol, I-61100 Pesaro, Italy
来源
COOLEYS ANEMIA: SEVENTH SYMPOSIUM | 1998年 / 850卷
关键词
D O I
10.1111/j.1749-6632.1998.tb10485.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
After successful marrow transplantation (BMT) iron overload remains an important cause of morbidity in Thalassemia, After BMT, patients hare normal erythropoiesis capable of producing a hyperplastic response to phlebotomy so that this procedure can be contemplated as a method of mobilizing iron from overloaded tissues. Forty-one patients (mean age 16+/-2.9 years) with prolonged follow-up (range 2-7 years) after BMT were submitted to a moderate intensity phlebotomy program (6 ml/kg blood withdrawal at 14-day intervals) to reduce iron overload. Values are expressed as mean +/- SD or as median with a range (25(th)-75(th) percentile). Serum ferritin decreased from 2,587 (2,129-4,817) to 250 (132-920) mu g/l (p < 0.0001), total transferrin increased from 2.34 +/- 0.37 to 2.9 +/- 0.65 g/l (p = 0.0001), transferrin saturation decreased from 90% +/- 14% to 39% +/- 34% (p < 0.0001). Liver iron concentration evaluated on liver biopsy specimens decreased from 20.8 (15.5-28.1) to 3 (0.9-14.6) mg/g dry weight (p < 0.0001). Alanine amino-transaminase from 5.2 +/- 3.4 to 1.6 +/- 1.2 (p < 0.0001) times the upper level of normality. The histological grading for chronic hepatitis (Histology Activity Index) decreased from 4.2 +/- 2.4 to 2.3 +/- 1.8 (p < 0.0001), Phlebotomy is a safe, efficient, and widely applicable method to decrease iron overload in "ex-thalassemic.".
引用
收藏
页码:288 / 293
页数:6
相关论文
共 18 条
[1]   TO C OR NOT TO C - THESE ARE THE QUESTIONS [J].
ALTER, HJ .
BLOOD, 1995, 85 (07) :1681-1695
[2]   Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia [J].
Andreani, M ;
Manna, M ;
Lucarelli, G ;
Tonucci, P ;
Agostinelli, F ;
Ripalti, M ;
Rapa, S ;
Talevi, N ;
Galimberti, M ;
Nesci, S .
BLOOD, 1996, 87 (08) :3494-3499
[3]   Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation [J].
Angelucci, E ;
Muretto, P ;
Lucarelli, G ;
Ripalti, M ;
Baronciani, D ;
Erer, B ;
Galimberti, M ;
Giardini, C ;
Gaziev, D ;
Polchi, P ;
Rovelli, A ;
Monguzzi, W ;
Masera, G ;
Piga, A ;
Garofalo, F ;
Gabutti, V ;
DiGregorio, F ;
Romeo, MA ;
Cammella, A ;
Russo, G ;
Gallisai, D ;
Burrai, C ;
Costi, C ;
Marinaro, AM ;
Erbeia, M ;
Mazzani, D ;
Nobili, B ;
Perrotta, S ;
Ferrara ;
Cutillo, S ;
Mulas, G ;
Careddu, F ;
Mancini, E ;
Argiolu, F ;
Addari, C ;
Ruggiero, L ;
DeNunzio, A ;
Terzoli, S ;
DAscola, G ;
Bruciatelli, M ;
Satta, AM ;
BorgnaPignatti, C ;
Marradi, P ;
Puggioni, G ;
Murgia, T ;
Porta, E ;
Poggi, V ;
PintaBoccalatte, MF ;
Polizzi, B ;
Maroni, P .
BLOOD, 1997, 90 (03) :994-998
[4]  
ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757
[5]  
BARTON AL, 1995, AM J CLIN PATHOL, V103, P419
[6]   HEPATIC IRON STORES AND PLASMA FERRITIN CONCENTRATION IN PATIENTS WITH SICKLE-CELL-ANEMIA AND THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
COHEN, AR ;
MCLAREN, CE ;
MARTIN, MB ;
GRIFFITH, PM ;
NIENHUIS, AW ;
YOUNG, NS ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (01) :81-85
[7]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[8]  
FINCH CA, 1986, WESTERN J MED, V145, P657
[9]   The treatment of chronic viral hepatitis [J].
Hoofnagle, JH ;
DiBisceglie, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :347-356
[10]   FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS [J].
KNODELL, RG ;
ISHAK, KG ;
BLACK, WC ;
CHEN, TS ;
CRAIG, R ;
KAPLOWITZ, N ;
KIERNAN, TW ;
WOLLMAN, J .
HEPATOLOGY, 1981, 1 (05) :431-435